The growth of Viagra and its influence on the drug landscape presents a complicated question for shareholders. While the first sales data were astounding, the intellectual property has expired, leading to a deluge of https://mattierasg786945.blogitright.com/41727599/viagra-and-big-pharma-a-risky-opportunity